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catabolic conditions such as aging and diabetes, IGF signaling is
impaired and fibrosis develops in skeletal muscles. To examine
whether impaired IGF signaling initiates muscle fibrosis, we gener-
ated IGF-IR/ heterozygous mice by crossing loxP-floxed IGF-IR
(exon 3) mice with MyoD-cre mice. IGF-IR/ mice were studied
because we were unable to obtain homozygous IGF-IR-KO mice. In
IGF-IR/ mice, both growth and expression of myogenic genes
(MyoD and myogenin; markers of satellite cell proliferation and
differentiation, respectively) were depressed. Likewise, in injured
muscles of IGF-IR/ mice, there was impaired regeneration, de-
pressed expression of MyoD and myogenin, and increased expression
of TGF-1, -SMA, collagen I, and fibrosis. To uncover mechanisms
stimulating fibrosis, we isolated satellite cells from muscles of IGF-
IR/ mice and found reduced proliferation and differentiation plus
increased TGF-1 production. In C2C12 myoblasts (a model of satel-
lite cells), IGF-I treatment inhibited TGF-1-stimulated Smad3 phos-
phorylation, its nuclear translocation, and expression of fibronectin.
Using immunoprecipitation assay, we found an interaction between
p-Akt or Akt with Smad3 in wild-type mouse muscles and in C2C12
myoblasts; importantly, IGF-I increased p-Akt and Smad3 interaction,
whereas TGF-1 decreased it. Therefore, in muscles of IGF-IR/
mice, the reduction in IGF-IR reduces p-Akt, allowing for dissociation
and nuclear translocation of Smad3 to enhance the TGF-1 signaling
pathway, leading to fibrosis. Thus, strategies to improve IGF signaling
could prevent fibrosis in catabolic conditions with impaired IGF
signaling.
transforming growth factor-1; insulin-like growth factor I; satellite
cells; myogenesis; fibrosis; Smad3
SATELLITE CELLS REPRESENT A DISTINCT LINEAGE of myogenic
progenitor cells that are responsible for postnatal growth,
repair, and maintenance of skeletal muscle (34). Normally,
satellite cells are quiescent in adult muscle, but following
muscle injury they are converted into myoblasts that proliferate
and migrate to the site of injury to differentiate and form new
myofibers (15).
Growth factors influence the processes of satellite cell acti-
vation and muscle regeneration in injured muscles of rodents.
Of these, the most extensively studied are hepatocyte growth
factor (24), basic fibroblast growth factor (2), insulin-like
growth factor I (IGF-I) and IGF-II, transforming growth
factor- (TGF-), and others. For example, hepatocyte
growth factor can promote quiescent satellite cells to enter
the cell cycle to stimulate muscle regeneration (24); local
expression of a muscle-specific IGF-I transgene increases
satellite cell function to accelerate muscle regeneration (3,
11, 25, 27). In vitro, TGF- can depress satellite cell prolif-
eration and differentiation in a dose-dependent manner (1).
TGF-1 also induces transdifferentiation of satellite cells into
myofibroblasts that produce fibrosis and hinder regeneration of
injured muscles (20). In contrast, suppression of TGF-1
signaling inhibits fibrosis and improves muscle regeneration
(23). However, whether growth factors and their signaling
pathway interact to regulate satellite cell function and muscle
regeneration is unclear.
In muscles of animal models of aging, diabetes, or chronic
kidney disease (CKD), IGF/insulin intracellular signaling is
impaired, fibrous tissue is accumulated, and muscle regenera-
tion is decreased following injury (4, 7, 12, 13, 17). For
example, in injured muscles of mice with CKD, we found that
decreased function of IGF-I leads to satellite cell dysfunction,
decreased muscle regeneration, and an increase in muscle
fibrosis (46). However, the mechanism(s) by which impaired
IGF signaling causes fibrosis is unclear. Because of fibrotic
responses to TGF-1, we proposed that impaired IGF signaling
would promote fibrosis through a TGF-1-based mechanism.
To evaluate this hypothesis, we created mice that were
heterozygous IGF-IR-knockout mice, but only in MyoD-ex-
pressing cells. These transgenic mice had impaired muscle
growth, and their satellite cells exhibited decreased myogen-
esis and increased fibrogenesis. Our results identify an inter-
action between p-Akt and Smad3 that may be modulating
fibrosis in skeletal muscles of conditions with impaired IGF
signaling.
MATERIALS AND METHODS
Reagent and antibodies. Antibodies against p-Akt (Ser473), p-
Smad3 (Ser423/425), and Smad3 were from Cell Signaling Technology
(Beverly, MA). Antibodies against IGF-IR and TGF-1 were from
Santa Cruz Biotechnology (Santa Cruz, CA), against MyoD from
Vector Laboratories (Burlingame, CA), and against eMyHC and
myogenin from the Developmental Studies Hybridoma Bank (Uni-
versity Iowa, Iowa City, IA). Cardiotoxin, Sirius red, and antibodies
of anti-laminin, anti--smooth muscle actin (-SMA), and anti-
fibronectin were from Sigma-Aldrich (St. Louis, MO). The anti-
Ki67-Alexa Fluor 555 antibody was from BD Bioscience (San
Jose, CA), whereas DMEM and FBS were from Cellgro Mediatech
(Manassas, VA).
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Generation of mice lacking IGF-IR in MyoD-expressing cells.
Animal protocols were approved by the Baylor College of Medicine
Institutional Animal Care and Use Committees. Transgenic mice
bearing MyoD-Cre were a gift from Dr. D. J. Goldhamer (University
of Connecticut, Storrs, CT) (5). Mice with loxp-floxed IGF-IR (IGF-
IRflox/flox) were bred with MyoD-Cre mice (16). Mice with MyoD-Cre
and loxP-floxed IGF-IR were identified by genotyping (Cre primer:
5=-TGCCTGCATTACCGGTCGATG-3= and 5=-CCATGAGTGA-
ACGAACCTGGTCG-3=; IGF-IR-loxp primer: P1, 5=-CGCCTG-
GAAAAC TGCACG-3=; P2: 5=-AGCTGCCCAGGCACTCCG-3=; P3:
5=-GCAGGGGATACAGTACATGTTT-3=). RT-PCR produces 518 bp
(i.e., P1–P3) corresponding to IGF-IR exon 3 knockout, where the 574-bp
fragment indicated the intact IGF-IR gene (6, 16) (Fig. 1A). We were
unable to obtain homozygous IGF-IR-knockout mice, so we studied
heterozygous IGF-IRflox//MyoD-Cre mice (refered as IGF-IR/).
Muscle regeneration. IGF-IR/ and control (IGF-IRflox/flox) mice
were studied at 6–10 wk of age. Muscle injury is induced by
cardiotoxin (CTX) injection to activate satellite cells and muscle
regeneration because CTX induces myofiber degeneration but does
not affect satellite cells, blood vessels, or muscle innervation (9).
Briefly, 80 l of 10 M CTX in saline was injected into one tibialis
anterior (TA) muscle of anesthetized mice, using a 27-gauge needle.
The contralateral muscle was injected with same volume of PBS and
served as an uninjured control muscle. After different periods, mice
were anesthetized and perfused with PBS via puncture of the left
ventricle. Muscles were either frozen in isopentane chilled with dry
ice for histological analyses or frozen and stored at 80°C until
proteins or RNAs were evaluated.
Satellite cell isolation. Satellite cells were isolated from 2-wk-old
young mice and identified by previously described methods (46).
Satellite cell proliferation was assessed using a percentage of Ki-67-
positive nuclei to total nuclei. TGF-1 in medium from cultured
satellite cells was analyzed by ELISA (Promega, Madison, WI).
Differentiation assays. C2C12 cells (ATCC, Manassas, VA) or
isolated satellite cells were differentiated into myotubes as described
(42). Myotubes were fixed in 2% paraformaldehyde for 10 min before
immunostaining for embryonic myosin heavy chain (eMyHC). The
differentiation index was calculated as the percentage of nuclei within
Fig. 1. IGF-IR/ impairs IGF-I signaling in
mouse muscle and decreases muscle growth.
A: genomic analysis (PCR) confirms deletion
of exon 3 of the IGF-IR in IGF-IR/ mice
(n  6 mice in each group). B: representative
Western blots of the indicated proteins in mus-
cles of control (CTRL; IGF-IRlox/lox) or IGF-
IR/ mice (left). Band densities corrected for
GAPDH are on the right (n  4 mice in each
group). C: representative Western blots of the
indicated proteins in heart and liver of CTRL
or IGF-IR/ mice (left). Band densities cor-
rected for GAPDH or Akt are on the right (n
4 mice in each group). D: body weights of
CTRL and IGF-IR/ mice at 3 and 12 wk
after birth (n 5 mice in each group). E: ratios
of muscle weight to tibia length in CTRL or
IGF-IR/ mice at 12 wk of age (soleus,
soleus muscle; TA, tibialis anterior; gas, gas-
trocnemius; n 5 mice in each group). F, top:
cross-sections of TA muscles were immuno-
stained with anti-laminin (bar, 50 m); bot-
tom: myofiber areas were used to determine
the percentage of myofibers in a defined area
to total no. of myofibers measured (total of 500
myofibers were measured from each group of
4 mice). G: the mean  SE size of myofibers
found in F; n  4 mice in each group. *P 
0.05 vs. CTRL.
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myotubes that was positively stained for eMyHC plus the number of
eMyHC positive-mononuclear cells to the total number of nuclei in
the area (43). In striated muscles there are multiple forms of myosin
heavy chains encoded by different genes, producing tissue-specific
and developmentally regulated expression. We studied eMyHC pro-
tein representing embryonic myosin heavy chain, which is progres-
sively lost during postnatal development. Notably, eMyHC is ex-
pressed during muscle regeneration. The individual counting the fibers
was masked to treatment or physiological conditions.
RT-PCR analysis. RT-PCR was performed as described (45, 46),
and relative gene expression was calculated from cycle threshold
(CT)values using GAPDH as an internal control [relative expres-
sion  2(sample CT  GAPDH CT)]. Primer sequences have been
reported (44).
Immunohistochemical analyses. Serial, transverse cryosections (8
m) of TA muscles were air-dried and fixed in cold acetone or 4%
paraformaldehyde for 10 min. They were stained with hematoxylin
and eosin (H & E); other sections were examined for collagen and
fibrosis using Sirius red staining (46).
To calculate cross-sectional areas of individual myofibers, cross-
sections of TA muscles were immunostained with anti-laminin to
identify the basement membrane. Myofiber sizes were measured using
Nikon NIS-Elements Br 3.0 software (Melville, NY), and the myofi-
ber sizes were expressed as the percentage of myofibers within the
specified range. The individual counting the myofibers was masked to
treatment and physiological conditions.
Immunoprecipitation assay. Lysates of gastrocnemius muscles (1
mg) from wild-type mice were incubated with anti-Akt or anti-p-Akt
conjugated to sepharose beads and shaken overnight at 4°C. The beads
were washed five times with PBS, and Western blots were performed
using anti-Smad3 or p-Smad3. Alternatively, the lysate was immuno-
precipitated with anti-Smad3 or anti-p-Smad3 overnight at 4°C. After
the addition of 30 l of Protein A/G Plus beads for 2 h at 4°C, the
beads were washed five times with PBS, and Western blots were
performed using anti-Akt or p-Akt. C2C12 myoblasts were treated
with IGF-I (10 ng/ml), TGF-1 (4 ng/ml), or both for 30 min. Cell
lysates (500 g) were immunoprecipitated using methods and anti-
bodies as described above.
Statistical analysis. Results are expressed as means  SE. Signif-
icance testing was performed using one-way ANOVA, followed by
pairwise comparisons using the Student-Newman-Keuls test. Statisti-
cal significance was set at P  0.05. A minimum of three replicates
was performed for each experimental condition.
RESULTS
Mice with IGF-IR/ impair IGF signaling in mouse
muscle and decrease muscle growth. Using the strategy
described before (6, 16), we confirmed that IGF-IR/ mice
had deletion of exon 3 (Fig. 1A). In muscles of these mice,
the IGF-IR protein was 	50% lower than in muscles of
control IGF-IRflox/flox mice (Fig. 1B). In lysates of muscles
from IGF-IR/ mice, the levels of p-Akt, MyoD, and
myogenin were also lower vs. the results from control mice
(Fig. 1B). To test whether IGF-IR/ affected the other
tissues, we assessed the hearts and livers of control and
IGF-IR/ mice. We found no significant differences in the
levels of IGF-IR or p-Akt in the hearts or livers of control
or IGF-IR/ mice, although there was a slight reduction of
protein in IGF-IR/ mice (Fig. 1C). Thus, the major
response of IGF-IR knockout in MyoD-expressing cells
occured in skeletal muscles. At 3 wk of age, body weights of
IGF-IR/ and control mice were not significantly different,
but at 12 wk of ag, the weight of IGF-IR/ mice was
significantly lower than that of control mice (Fig. 1D). In
IGF-IR/ mice, the ratio of muscle weight to tibia length was
significantly lower than in control mice (Fig. 1E). Mixed-fiber
TA and gastrocnemius muscles were decreased by 10.34 1.5
and 14.81  3.08%, respectively, compared with values in
control mice, whereas the decrease in the red fiber soleus
muscle was 12.33  2.97%. However, the magnitude decrease
in weight among the three different types of muscles was not
significantly different. Therefore, different types of muscle
fibers are equally affected in IGF-IR/ mice. Next, we mea-
sured sizes of myofibers in TA muscles from IGF-IR/ and
wild-type mice. The distribution of myofiber sizes in IGF-
IR/ vs. control mice was shifted to the left, with an average
size of 1,959.88  32.1 (in IGF-IR/ mice) vs. 2,145.1 
36.1 m2 (control mice) (P  0.05; Fig. 1, F and G).
Mice with IGF-IR/ had decreased satellite cell function.
We isolated satellite cells from muscles of IGF-IR/ and
control mice. These cells had significantly reduced expression
of IGF-IR and p-Akt as well as MyoD and myogenin (Fig. 2A),
which are markers of satellite cell proliferation and differenti-
ation, respectively. In satellite cells from muscles of IGF-
IR/ mice there was decreased proliferation, as assesed by
Ki-67 immunostaining (Fig. 2B). There was also impaired
differentiation as evaluated by immunostaining for embryonic
myosin heavy chain, which is expressed in muscle regeneration
(eMyHC; Fig. 2C). In isolated satellite cells from muscles of
IGF-IR/ mice, there was increased fibronectin expression
plus production of 50% more TGF-1 vs. values from satellite
cells isolated from control mice (Fig. 2, D and E). Therefore,
impaired IGF signaling in satellite cells decreases their prolif-
eration and differentiation into myotubes while stimulating
TGF-1 production and markers of fibrosis.
IGF-IR/ impairs muscle regeneration. Next, we used
CTX-induced muscle injury to examine satellite cell activa-
tion in vivo (27, 46). At 3 days after injury, the mRNA
levels of myogenic genes, MyoD, and myogenin were max-
imal in muscles of both groups of mice (Fig. 3, A and B).
But at 2, 3, or 11 days after injury, both MyoD and
myogenin mRNAs were significantly lower in muscles of
IGF-IR/ mice. By 14 days, the mRNAs in both groups
had returned to preinjury levels.
H & E staining of cross-sections of injured TA muscles
revealed slowed muscle regeneration in IGF-IR/ mice. At
5 or 7 days after injury, muscles from IGF-IR/ mice had
fewer newly formed myofibers, as indicated by central
nuclei (Fig. 3, C and D), and at 14 days after injury, space
between myofibers persisted (Fig. 3C), and the distribution
of newly formed myofiber sizes was shifted toward smaller
sizes, with an average size of 1,147.5  20.8 vs. 1,417.2 
26.0 m2 (P  0.05; Fig. 3, E and F). Thus, reduced IGF
signaling impairs satellite cell function in vivo to decrease
muscle regeneration.
Muscle injury stimulates fibrosis in muscle of IGF-IR/
mice. Muscle injury increased IGF-IR expression in muscle of
control mice but not in muscle of IGF-IR/ mice (Fig. 4A).
In injured muscle of IGF-IR/ mice, there was increased
TGF-1 mRNA and protein expression (Fig. 4, B and C).
Specifically, there was evidence for increased TGF-1 sig-
naling, as p-Smad3 was increased in injured muscles of
IGF-IR/ mice (Fig. 4C). These results are consistent with
an increase in protein and mRNAs of -SMA (Fig. 4, C and
D) and mRNA of collagen I (Fig. 4E) as well as accumula-
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tion of collagen (Sirius red staining; Fig. 4F) following injury.
However, in uninjured muscles of IGF-IR/ mice, the protein
levels of TGF-1, collagen I, -SMA, or p-Smad3 were not
significantly changed vs. control mice (Fig. 4G). Therefore, in
injured muscles of IGF-IR/ mice, TGF-1 increases and
promotes fibrosis.
IGF-I inhibits TGF-1-suppressed muscle cell differentia-
tion and increased fibrosis. Next, we examined how a decrease
in IGF-IR promotes fibrosis in injured muscles. We stimulated
C2C12 myoblasts by placing them in differentiation media with
IGF-I (10 ng/ml), TGF-1 (4 ng/ml), or both. After 96 h we found
that TGF-1 blunted C2C12 differentiation into myotubes,
whereas IGF-I blocked the responses to TGF-1 (Fig. 5A). When
C2C12 myoblasts were treated with TGF-1, IGF-I, or both for
8 h, TGF-1 alone increased fibronectin expression, and IGF-I
significantly inhibited this TGF-1 response (Fig. 5, B and C).
The interaction of p-Akt with Smad3 blocks Smad3 nu-
clear translocation. To identify how reduced IGF-IR in
MyoD-expressing cells leads to fibrosis following muscle
injury, we treated C2C12 myoblasts with IGF-I, TGF-1, or
both for 30 min. Western blots of cell lysates revealed that
IGF-I raised p-Akt, whereas TGF-1 increased the p-Smad3
level. But when IGF-I and TGF-1 were combined, the
p-Smad3 level was decreased vs. results in cells treated with
TGF-1 alone (Fig. 6A). To test whether the IGF-I-induced
increase in p-Akt regulates Smad3 activation, we evaluated
Smad3 nuclear translocation in C2C12 myoblasts. TGF-1
stimulated the nuclear translocation of Smad3, and the
addition of IGF-I markedly suppressed it. In these cells, we
also found that p-Akt colocalized with Smad3 in the cyto-
plasm of C2C12 myoblasts (Fig. 6B). Thus, IGF-I signaling
can suppress TGF-1 signaling in myoblasts and prevent
Smad3 translocation into the nucleus.
Next, we isolated satellite cells from muscles of IGF-IR/
mice. Compared with satellite cells from control mice, satellite
cells from muscle of IGF-IR/ mice had lower levels of
IGF-IR or p-Akt but increased Smad3 in the nuclei (Fig. 6C).
We also noticed the nuclei staining of IGF-IR or p-Akt in
Fig. 2. IGF-IR/ decreases satellite cell
functions. A, left: representative Western
blots of the indicated proteins in satellite
cells isolated from muscles of CTRL or
IGF-IR/ mice; right: band densities (n 
3 mice in each group). B: the percentage of
Ki-67-positive cells to total satellite cells
was calculated to identify a proliferation rate
(bar, 50 m; satellite cells were isolated
from 3 mice, and the experiments were re-
peated 3 times). C, left: differentiated satel-
lite cells were immunostained with an anti-
body against embryonic myosin heavy chain
(eMyHC; green); right: the differentiation
index was calculated as described in MATE-
RIALS AND METHODS. (bar, 50 m; satellite
cells were isolated from 2 mice, and the
experiments were repeated 3 times). D: sat-
ellite cells were immunostained for fibronec-
tin (green; bar, 50 m). Two mice in each
group were used to isolate satellite cells,
and the experiments were repeated 3 times.
E: total transforming growth factor-1
(TGF-1) was measured in media from
incubated satellite cells of control or IGF-
IR/ mice (n  3 mice in each group, and
the measurements were repeated 3 times).
*P  0.05 vs. CTRL.
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satellite cells of IGF-IR/ mice, which could reflect from
DAPI channel leakage upon extended exposure. There also
was colocalization of p-Akt and Smad3 in satellite cells of
control mice. These results provide in vivo evidence for a
cross-talk between the IGF-I and TGF-1 signaling.
From the results with muscle cells, we proposed that
p-Akt sequesters Smad3 in the cytoplasm and suppresses
TGF-1 signaling (there is evidence from cancer cells that
Akt associates with Smad3) (8, 28). To test our proposal, we
immunoprecipitated muscle lysates with anti-Akt, anti-p-
Akt, anti-Smad3, or anti-p-Smad3. Each immunocomplex
was immunoblotted with anti-Smad3, anti-p-Smad3, anti-
Akt, or anti-p-Akt. The results of these immunoprecipita-
tion/Western blotting experiments indicate that both p-Akt
and Akt associate with Smad3 but not p-Smad3 in muscles
of wild-type mice (Fig. 6D). The major form of Akt inter-
acting with Smad3 is p-Akt (Fig. 6D). Besides evaluating
the proposal in mouse muscles, we treated C2C12 myoblasts
with IGF-I, TGF-1, or both for 30 min. Cell lysates were
immunoprecipitated with antibodies to Smad3, p-Smad3,
Akt, or p-Akt, and their immunocomplexes were subjected
to Western blot with the indicated proteins (Fig. 6E). Re-
sults from these experiments showed that Akt or p-Akt
associates with Smad3 but not p-Smad3. However, IGF-I
increased the association of Smad3 with p-Akt. In contrast,
TGF- treatment decreased the association of Smad3 with
p-Akt (Fig. 6E).
DISCUSSION
Catabolic conditions of impaired IGF/insulin signaling
(i.e., CKD, diabetes, or aging) lead to reduced satellite cell
function and muscle regeneration and increased muscle
fibrosis (46). However, how impaired IGF-I/insulin signal-
ing leads to fibrosis has not been elucidated. In muscles
from IGF-I/ mice we found reduced levels of IGF-IR,
p-Akt, MyoD, and myogenin, which lead to worsening
muscle regeneration and fibrosis vs. results from control
Fig. 3. IGF-IR/ impairs muscle regenera-
tion. In injured mouse muscle, mRNAs of
MyoD (A) or myogenin (B) corrected for
GAPDH were evaluated by RT-PCR (n  4
mice at each time point). C: hematoxylin and
eosin-stained cross-sections of TA muscles
at 5, 7, and 14 days after injury (bar, 20 m;
4 control or IGF-IR/mice at each time point
were evaluated). D: average no. of myofibers
from 5 areas in C, with central nuclei (i.e.,
newly formed myofibers) counted (n 4 mice
in each group). E: at 14 days after injury, the
distribution of the cross-sectional areas of
newly formed myofibers in TA muscles was
calculated (a total of 700 new generated myo-
fibers were measured from 4 wild-type CTRL
or IGF-IR/ mice). F: mean  SE size of
newly produced myofibers found in E; n  4
mice in each group. *P  0.05 vs. CTRL.
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mice. Interestingly, the magnitude of decrease in the expres-
sion of myogenin in muscles of IGF-IR/ mice was less
than the decrease in IGF-IR, p-Akt, or MyoD. This presum-
ably represents differing responses of genes that control
satellite cell functions. For example, in mutant mice lacking
both Myf5 and MyoD, skeletal muscle was not formed (31),
but in mice lacking myogenin, myoblasts were unaffected,
but muscle fibers were scarce (14, 26).
We also noticed that muscle weight and total body weight
had similar reductions in IGF-IR/ mice, and this could be
due to the fact that skeletal muscle (plus fat) constitutes
	60 – 80% of body weight in rats (30) and 	40 – 45% in
humans, and therefore, loss of muscle will decrease total
body weight. In addition, we found that satellite cells
isolated from muscle of IGF-IR/ mice had significantly
reduced expression of IGF-IR and p-Akt as well as MyoD
and myogenin, but the expression of the IGF-IR in satellite
cells was lower than the IGF-IR level we detected in
muscles of IGF-IR/ mice. This difference could represent
the total level of IGF-IR from muscle, blood vessels, and
interstitial tissues as well as satellite cells compared with the
results of isolated satellite cells.
An interaction between IGF-I and TGF-1 signaling has
been reported. In epithelial or hematopoietic cells it was
shown that Akt interacts with Smad3, but the roles of Akt
and p-Akt are controversial. In one report, p-Akt did not
promote an interaction with Smad3, but in another report it
was concluded that p-Akt is required for the inhibition of
Fig. 4. IGF-IR/ increases fibrosis in injured
muscle. A: representative Western blots of
IGF-IR from lysates of TA muscles 3 days
after injury (n  4 mice in each group).
B: mRNA expression of TGF-1 in injured
TA muscles of CRTL and IGF-IR/ mice
(*P  0.05 vs. values of control mice at
different times; n  4 mice at each time). C,
left: representative Western blots of proteins in
lysates of injured TA muscles; right: the den-
sity of bands representing different genes are
corrected for GAPDH (*P  0.05 vs.
CTRL; n  4 mice at each group). D and
E: mRNAs of -smooth muscle actin (-
SMA; D) and collagen I (E) in injured TA
muscles of control and IGF-IR/ mice
(*P  0.05 vs. CTRL; n  4 mice in each
group). F: cross-sections of TA muscles
obtained at 7 or 14 days after injury were
stained with Sirius red. The yellow-red
color indicates collagen I deposition (bar, 50
m; n  4 mice in each group). G, top:
representative Western blots of proteins in
uninjured muscles of control and IGF-IR/
mice at 12 wk of age (n  6 control or
IGF-IR/ mice); bottom: the density of
TGF-1 bands is corrected for GAPDH (n
4 mice at each group).
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Smad3 phosphorylation (8, 28). Our results indicate that
both Akt and p-Akt are associated with Smad3 in mouse
muscle and C2C12 myoblasts. However, it appears that
p-Akt is the major mediator regulating nuclear translocation
of Smad3. Also, we found that a decrease in p-Akt in
satellite cells isolated from IGF-IR/ mice led to an
increase in Smad3 translocation into nuclei. When C2C12
cells were treated with IGF-I, p-Akt increased in the cyto-
plasm and was associated with Smad3, preventing Smad3
from mediating TGF-1 signaling.
Satellite cell heterogeneity has been widely investigated,
and it has been shown that both human and porcine satellite
cells can differentiate into mature adipocytes (10, 36).
Others conclude that individual satellite cells and their
progeny can adopt only a single developmental fate (35),
and Starkey et al. (39) concluded that satellite cells are
committed to myogenesis and do not spontaneously adopt
nonmyogenic fates. To explain why “satellite cells” isolated
from IGF-IR/ mice produce more TGF-1 vs. satellite
cells from control mice, two possibilities exists: 1) isolated
satellite cells could be a mix of two types of cells, muscle
progenitor cells and cells with fibrogenic potential (19); or
2) satellite cells respond to impaired IGF signaling by
developing into fibroblast cells through a TGF-1-stimu-
lated pathway. Regardless, our report shows for the first
time that IGF-I and TGF-1 signaling are interacting in
mouse satellite cells, determining the fate of satellite cells to
either myogenesis or fibrogenesis.
There is evidence that Smad3 exerts an antimyogenic effect
by a mechanism that depends on transcriptional repression of
MyoD plus an inhibition of satellite cell differentiation into
myotubes (21, 32). For example, in the mdx mouse, inhibition
of p-Smad3 with halofuginone was shown to suppress muscle
fibrosis and improve skeletal muscle function (18, 29, 41). In
agreement with these conclusions that p-Smad3 interferes with
myogenesis, we found that treatment with TGF-1 increases
translocation of Smad3 into nuclei and suppresses myoblast
differentiation into myotubes (Fig. 5A) that may be responsible
for worsening fibrosis.
In our experiments, we chose to study Smad3 rather than
Smad2 because targeted knockdown of Smad2 in cultured
human myoblasts only modestly reduced the ability of TGF-1
to impair myotube formation. In contrast, loss of Smad3 or
knockdown of Smad2 and Smad3 together was shown to
sharply increase myotube formation (40). Similarly, Smad3
knockout has been shown to exert a major change in the
differentiation into myotubes that occurs when cells were
treated with TGF-1; in those experiments, Smad2 KO re-
sulted in only a small response (21, 22, 33).
Taken together, our results demonstrate that stimulation of
IGF-IR signaling not only blocks TGF-1-induced fibrosis in
muscle but may also interrupt TGF-1 signaling. This results
in prevention of activation of Smad3 and its translocation into
nuclei, where it increases mediators of fibrosis. Thus, the
association of p-Akt with Smad3 in the cytoplasm in muscle or
satellite cells provides a novel mechanism by which myogensis
occurs and prevents fibrosis. Therefore, therapeutic strategies
to enhance this association may prove beneficial in muscle
injury.
Fig. 5. IGF-I suppresses TGF-1-induced fi-
brosis. A, right: C2C12 cells were differentiated
in media with IGF-I, TGF-1, or both for 96 h
and then immunostained with anti-eMyHC;
left: the differentiation index (MATERIALS AND
METHODS) was calculated; n  3 repeats, P 
0.05 vs. untreated cells. B: C2C12 cells were
treated with IGF-I, TGF-1, or both for 8 h,
and cells were immunostained with fibronectin
(green; bar, 50 m; n  3 repeats). C: repre-
sentative Western blots for fibronectin in
C2C12 cells treated with IGF-I, TGF-1, or
both for 8 h (n  3 repeats). *P  0.05 vs.
nontreated cells; #P  0.05 vs. TGF-1-
treated cells.
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